Dabigatran prescribing information is updated
June 14th 2012Label prescribing information for dabigatran (Pradaxa, Boehringer Ingelheim) capsules has been updated to affirm that the 150-mg twice-daily dose is superior to warfarin in reducing ischemic and hemorrhagic strokes in patients with nonvalvular atrial fibrillation.
FDA approves pertuzumab for treatment of HER2-positive metastatic breast cancer
June 11th 2012FDA has approved pertuzumab (Perjeta, Roche) in combination with trastuzumab (Herceptin) and docetaxel chemotherapy for the treatment of people with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Digestive 3 in 1 Health liquid dietary supplement recalled for potential Salmonella contamination
June 8th 2012Botanical Laboratories Inc. is recalling 38 bottles of 33.8-oz. "Wellesse Digestive 3 in 1 Health" liquid dietary supplement and 275 bottles of 16-oz. liquid dietary supplement, after a supplier said one of the ingredients could be contaminated with Salmonella, which can be fatal in young children, frail and elderly people, and others with weakened immune systems.
U.S. House passes bill for purchase of OTC medications through FSAs, HSAs without prescription
June 8th 2012A bill has passed in the U.S. House of Representatives (H.R. 436, the "Protect Medical Innovation Act of 2012") that will allow consumers to purchase OTC medications through their flexible health spending accounts and health savings accounts without first obtaining a prescription.
Sandoz recalls some lots of generic Introvale due to packaging error
June 7th 2012Sandoz, a division of Novartis, is voluntarily recalling 10 lots of its generic oral contraceptive Introvale (levonorgestrel and ethinyl estradiol) tablets in the United States, after a consumer reported a packaging flaw.
Mixed results for intensive blood-sugar control
June 7th 2012Intensive control of blood-sugar levels among patients with type 2 diabetes mellitus may reduce the risk of microalbuminuria and macroalbuminuria, signs of kidney damage, but evidence is lacking regarding the effect over renal end points, according to the results of a study published May 28 in Archives of Internal Medicine.
HHS harnesses the power of health data to improve health
June 5th 2012The Health Data Initiative Forum III: The Health Datapalooza cohosted by the Institute of Medicine and the US Department of Health and Human Services (HHS) is convening this week in Washington, DC, focusing on innovative applications and services that harness the power of open data from HHS and other sources to help improve health and healthcare.